NCT05993390View on ClinicalTrials.gov

Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

August 14, 2025

Study Completion Date

August 30, 2025

Conditions
Neuromuscular BlockadeCritical IllnessNeurologic Findings
Interventions
DRUG

Sugammadex

Intravenous administration of sugammadex 2mg/kg.

DRUG

Neostigmine

Intravenous administration of neostigmine 0.05mg/kg with glycopyrrolate 0.01mg/kg

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER